anonymous
Guest
anonymous
Guest
Ask yourself if a lateral move from bad to bad is worth it? Do you want to "begin again" in another 8 months?
if you have a job run away from here as fast as you can
You should take the job and see for yourself. If you come to this site to make a career decision..you deserve it. Don't ask the question if you don't want the answer.Is it really that bad?
There are issues with Eisai as a whole but the bigger issues are with specific managers. Be aware of certain managers who've had recent high turnover. That will tell you everything you need to know.Is it really that bad?
Sounds like the culture in oncology is insanely toxic. But let's say somebody is already in a bad situation with another company that also has a toxic culture, insane goals, unreasonable metric expectations, micro-management, Challenger, the whole witches brew.
Is there any light at the end of the tunnel in Oncology there?
Is there a chance the massive loss of reps recently will cause upper management to rethink how they treat their people? Are there promising products in the pipeline for the future?
Been contacted by a recruiter and would appreciate honest answers. Is it worth a roll of the dice to take a job there if you're currently employed? Or should I not even waste my time exploring the opportunity?
If I do explore the situation what sort of salary demands should I make to make it worth my while to take a chance on this place? Will I have a reasonable chance to hit target bonus?
Thanks!
The story of Eisai Oncology is one of snatching defeat from the jaws of victory. So much good is within their grasp, but will they grab it?No management does not reflect. They still do not believe there is a turnover issue. They say turnover low. There will be no evolution in thinking.
Look up the pipeline for yourself. Weak. Limited investment in oncology. HCC in next year in very small market against Opdivo. Combo studies with Pembro still years away. Losing patent on Aloxi in 12 months.
I was with eisai for about six years, I left in last year. I launched Halaven and have seen many things come and go. I've seen that only about 10% of new drugs/indications that are hoped for and talked about ever come to fruition. For those which do, they're usually 2 years later than expected. Some of that is the way of the pharma world, but, Eisai is below average in this regard.The story of Eisai Oncology is one of snatching defeat from the jaws of victory. So much good is within their grasp, but will they grab it?
most of the decent folks that are left are too lazy to look for a new job
It will be interesting to see how many leave Oncology after July 1.Or we are just waiting for the right position. We will leave though.
It will be interesting to see how many leave Oncology after July 1.
Most have already put in their resignation. The company is just keeping is quiet. No retention issue here says Eisai which a third of the Salesforce quitting in the past four months.
Amy, Kevin.. the three more not officially done..
AS did the dude.
The story of Eisai Oncology is one of snatching defeat from the jaws of victory. So much good is within their grasp, but will they grab it?